is being presented by Bill Poston, Managing Partner, Kalypso and airs on Wednesday, September 8th, 2010. For more details or to register for this event, please visit our site at www.fxconferences.com
In today’s challenging market, an effective portfolio management process is essential to help medical device companies select those product ideas with the greatest commercial potential, and thereby maximize the return on their investments even when resources are limited. However, there is a big difference between portfolio management theory and how it is typically practiced in leading corporations. Product Portfolio Management (PPM) best practices and software should facilitate and support real-time portfolio analysis, but are they really being leveraged to their greatest benefit?
This audio conference presentation explores a practical, real-world approach to simple product portfolio management that will enable your company to define priorities and deliver on strategic objectives. The speaker provides valuable insight on six pragmatic PPM practices that add the most value with the least amount of effort.
Showing posts with label Kalypso. Show all posts
Showing posts with label Kalypso. Show all posts
Tuesday, August 17, 2010
Friday, April 30, 2010
Establishing an Effective Quality Management System: Benchmark Leading Practices
is being presented by Marcus Yoder, Senior Manager, with Kalypso and airs on Tuesday, May 25th, 2010. For more details or to register, please visit our site at www.fxconferences.com
Many medical device companies today have multiple design and development sites performing globally but operating in separate quality management systems (QMS) for product-related processes such as design, manufacturing, distribution, and service. To improve efficiency, consistency, and ease of information transfer, companies should move to harmonizing these systems in one global QMS.
This audio conference discusses ways in which for medical device companies can establish and manage an effective global QMS. Drawing on the results of a research benchmark study involving leading medical device manufacturers, this session looks at how companies are optimizing QMS processes to deliver business benefits and measure quality performance globally.
Many medical device companies today have multiple design and development sites performing globally but operating in separate quality management systems (QMS) for product-related processes such as design, manufacturing, distribution, and service. To improve efficiency, consistency, and ease of information transfer, companies should move to harmonizing these systems in one global QMS.
This audio conference discusses ways in which for medical device companies can establish and manage an effective global QMS. Drawing on the results of a research benchmark study involving leading medical device manufacturers, this session looks at how companies are optimizing QMS processes to deliver business benefits and measure quality performance globally.
Friday, March 19, 2010
Thinking Beyond Compliance: Medical Device Product Development
is being presented by Noel Sobelman, Partner, with Kalypso and airs on April 28th, 2010. For more details or to register, please visit our site at www.fxconferences.com
For today's medical device companies, implementing new product development (NPD) processes that comply with increasing regulatory requirements is a challenge. Many have inadvertently deployed overly bureaucratic systems and, as a result, have found themselves with increasing costs and slowing development.
This audio conference discusses recommendations for re-defining NPD processes and systems to balance compliance requirements with time-to-market and development effectiveness initiatives. Based on the results of a research study involving 20 medical device companies, the presentation explores how they find the right balance between what can seem like competing objectives.
For today's medical device companies, implementing new product development (NPD) processes that comply with increasing regulatory requirements is a challenge. Many have inadvertently deployed overly bureaucratic systems and, as a result, have found themselves with increasing costs and slowing development.
This audio conference discusses recommendations for re-defining NPD processes and systems to balance compliance requirements with time-to-market and development effectiveness initiatives. Based on the results of a research study involving 20 medical device companies, the presentation explores how they find the right balance between what can seem like competing objectives.
Subscribe to:
Posts (Atom)